{"id":672560,"date":"2026-07-23T06:02:14","date_gmt":"2026-07-23T06:02:14","guid":{"rendered":"https:\/\/www.europesays.com\/es\/672560\/"},"modified":"2026-07-23T06:02:14","modified_gmt":"2026-07-23T06:02:14","slug":"carlos-martin-considera-un-hito-que-se-haya-probado-la-vacuna-mtbvac-en-5-500-adolescentes-y-adultos","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/es\/672560\/","title":{"rendered":"Carlos Mart\u00edn considera un \u00abhito\u00bb que se haya probado la vacuna MTBVAC en 5.500 adolescentes y adultos"},"content":{"rendered":"<p class=\"c-paragraph\"><b>La vacuna candidata contra la tuberculosis MTBVAC\u00a0<\/b>dise\u00f1ada por el equipo del investigador aragon\u00e9s de la Universidad de Zaragoza Carlos Mart\u00edn Monta\u00f1es <b>sigue cosechando \u00e9xitos<\/b> en su prolongada carrera para sustituir a la actual BCG. As\u00ed, su creador ha calificado de \u00abhito\u00bb que<a href=\"https:\/\/www.heraldo.es\/noticias\/salud\/2026\/07\/22\/seguridad-eficacia-vacuna-contra-tuberculosis-creada-universidad-zaragoza-probada-personas-2039156.html\" title=\"La seguridad y eficacia de la vacuna contra la tuberculosis dise\u00f1ada en Arag\u00f3n, probada en 5.500 adolescentes y adultos\" rel=\"nofollow noopener\" target=\"_blank\"> 5.500 adolescentes y adultos sanos<\/a>, con edades comprendidas entre los 14 y los 45 a\u00f1os, hayan sido vacunados con Mtbvac para probar su eficacia e inmunogenicidad.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"La vacuna candidata contra la tuberculosis MTBVAC\u00a0dise\u00f1ada por el equipo del investigador aragon\u00e9s de la Universidad de Zaragoza&hellip;\n","protected":false},"author":2,"featured_media":672561,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[92],"tags":[104642,25,24,165,166,23,21831,8177],"class_list":["post-672560","post","type-post","status-publish","format-standard","has-post-thumbnail","category-salud","tag-carlos-martin","tag-es","tag-espana","tag-health","tag-salud","tag-spain","tag-tuberculosis","tag-vacuna"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@es\/116967777533375368","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/posts\/672560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/comments?post=672560"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/posts\/672560\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/media\/672561"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/media?parent=672560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/categories?post=672560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/es\/wp-json\/wp\/v2\/tags?post=672560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}